On May 8, 2020, the U.S. Food and Drug Administration (FDA) approved Retevmo (selpercatinib), an oral RET inhibitor developed by Eli Lilly's subsi···【Read More】
Update: 2026-05-29Source: Haiou HealthViews: 97
Ixazomib was approved by the U.S. Food and Drug Administration (FDA) on November 20, 2015, for the treatment of adult patients with relapsed or refrac···【Read More】
Update: 2026-05-28Source: Haiou HealthViews: 101
Ixazomib is an oral proteasome preparation. Platelet counts should be monitored at least monthly during treatment, with increased monitoring frequency···【Read More】
Update: 2026-05-28Source: Haiou HealthViews: 97
Ixazomib is an oral proteasome preparation. When used in combination with lenalidomide and dexamethasone, it can cause side effects such as diarrhea, ···【Read More】
Update: 2026-05-28Source: Haiou HealthViews: 101
Ixazomib is an oral proteasome preparation that provides an important treatment option for patients with multiple myeloma.What disease does ixazomib t···【Read More】
Update: 2026-05-28Source: Haiou HealthViews: 99
Ixazomib is an orally administered, highly selective proteasome inhibitor that must be used in combination with lenalidomide and dexamethasone.Ixazomi···【Read More】
Update: 2026-05-28Source: Haiou HealthViews: 100
Ixazomib is covered by medical insurance and is reimbursable.What is the price of Ixazomib in China?Ixazomib is reimbursable by medical insurance, sig···【Read More】
Update: 2026-05-27Source: Haiou HealthViews: 101
Ixazomib offers an important treatment option for patients with multiple myeloma.How to Purchase IxazomibPatients meeting the indications can signific···【Read More】
Update: 2026-05-27Source: Haiou HealthViews: 91
Ixazomib should be taken under the guidance of a professional physician and should not be taken without medical supervision.Ixazomib Usage Guidelines1···【Read More】
Update: 2026-05-27Source: Haiou HealthViews: 93
Ixazomib is the world's first oral proteasome inhibitor. Specific usage and dosage must be strictly followed as directed by your doctor.How to Use···【Read More】
Update: 2026-05-27Source: Haiou HealthViews: 93
Ponatinib is a tyrosine kinase inhibitor that inhibits tumor cell proliferation by targeting and inhibiting the activity of the BCR-ABL fusion protein···【Read More】
Update: 2026-05-27Source: Haiou HealthViews: 95
Ponatinib is an oral tyrosine kinase inhibitor primarily used to treat certain types of leukemia that are resistant to or intolerant of prior treatmen···【Read More】
Update: 2026-05-26Source: Haiou HealthViews: 98
Ponatinib is a third-generation kinase inhibitor developed by Takeda Pharmaceutical Company of Japan, specifically designed for the treatment of adult···【Read More】
Update: 2026-05-26Source: Haiou HealthViews: 100
Ponatinib is used to treat T315I-positive chronic myeloid leukemia (CML) in the chronic, accelerated, or blast crisis phase in adults.Ponatinib Indica···【Read More】
Update: 2026-05-26Source: Haiou HealthViews: 102
In addition to its desired effects, ponatinib may cause some adverse reactions. While not all of these side effects will occur, if they do, medical at···【Read More】
Update: 2026-05-26Source: Haiou HealthViews: 99
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



